| 99076-2 |
Alpha-1-Microglobulin |
MCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
Alpha-1-Microglobulin [Mass/volume] in 24 hour Urine |
|
ADD |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
99076-2 |
|
|
|
|
Both |
|
|
|
0 |
A1 Microglob 24h Ur-mCnc |
|
|
|
N |
|
1 day; 24 hours; 24HR; A1; A1 Microglob; A1M; Alfa; Alpha-1-Microglycoprotein; Chemistry; HC; i; Level; Mass concentration; Microglob; Protein Human Complex; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 99077-0 |
Alpha-1-Fetoprotein.L3 |
MCnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
Alpha-1-Fetoprotein L3 [Mass/volume] in Serum or Plasma by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHEM |
|
99077-0 |
|
IA |
|
|
Both |
|
|
|
0 |
AFP L3 SerPl IA-mCnc |
|
|
|
N |
|
A1; AFP; AFP L3; Alfa; Alpha fetoprotein; Alphafetoprotein; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; Feto; i; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tumor marker |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 99078-8 |
Thyrotropin blocking Ab |
PrThr |
Ser |
Pt |
Ord |
CBA IFA |
|
ACTIVE |
Thyrotropin blocking Ab [Presence] in Serum by Cell binding immunofluorescent assay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
99078-8 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
TSH Block Ab Ser Ql CBA IFA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Endocrine; Endocrinology; Indirect Fluorescence Antibody; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; TBA; Thyroid stimulating hormone; Thyrotropic hormone; TSH; TSH Block |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99079-6 |
Acrylfentanyl |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
Acrylfentanyl [Presence] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
99079-6 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Acrylfentanyl Ur Ql Cfm |
|
|
|
N |
|
acryloylfentanyl; Addiction; C22H26N2O; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Egyptenyl; GCMS; Illicit; LC/MS/MS; N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]prop-2-enamide; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Synthetic opioid; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 9908-5 |
P wave duration.lead V2 |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
P wave duration in lead V2 |
|
MIN |
DefinitionDescription |
|
|
ms |
|
|
|
|
|
|
EKG.MEAS |
|
9908-5 |
|
EKG |
|
|
Observation |
|
|
|
0 |
P wave dur L-V2 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; P prime; P wave dur L-V2; Painter's colic; PB; Plumbism; Point in time; P-wave interval; QNT; Quan; Quant; Quantitative; Random |
2.48 |
1.0i |
|
|
|
|
|
|
|
ms |
|
|
|
0 |
| 99080-4 |
O-Nortramadol |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
O-nortramadol [Presence] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
99080-4 |
|
Confirm |
|
|
Both |
|
|
|
0 |
O-nortramadol Ur Ql Cfm |
|
|
|
N |
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmeth; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Tramadol metabolite; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99081-2 |
Furanylfentanyl |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
Furanylfentanyl [Presence] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
99081-2 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Furanylfentanyl Ur Ql Cfm |
|
|
|
N |
|
Addiction; C24H26N2O2; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Furanyl fentanyl; GCMS; Illicit; LC/MS/MS; N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Synthetic opioid; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99082-0 |
Coccidioides sp Ag |
MCnc |
Body fld |
Pt |
Qn |
IA |
|
ACTIVE |
Coccidioides sp Ag [Mass/volume] in Body fluid by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
MICRO |
|
99082-0 |
|
IA |
|
|
Both |
|
|
|
0 |
Coccidioides Ag Fld IA-mCnc |
|
|
|
N |
|
Antigen; Antigens; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Coccidiodes; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; Level; Mass concentration; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; species; spp; SUDS; Valley fever |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 99083-8 |
Blastomyces sp Ag |
MCnc |
Body fld |
Pt |
Qn |
IA |
|
ACTIVE |
Blastomyces sp Ag [Mass/volume] in Body fluid by Immunoassay |
|
NAM |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
MICRO |
|
99083-8 |
|
IA |
|
|
Both |
|
|
|
0 |
Blastomyces Ag Fld IA-mCnc |
|
|
|
N |
|
Antigen; Antigens; B/F; BF; Blasto; Blastomycosis; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; species; spp; SUDS |
2.73 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
Release 2.73: COMPONENT: Added word Ag for correction of component.; |
0 |
| 99084-6 |
Aspergillus sp Ag |
ACnc |
Body fld |
Pt |
Qn |
IA |
|
ACTIVE |
Aspergillus sp Ag [Units/volume] in Body fluid by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
Index |
|
|
|
|
|
|
MICRO |
|
99084-6 |
|
IA |
|
|
Both |
|
|
|
0 |
Aspergillus Ag Fld IA-aCnc |
|
|
|
N |
|
Antigen; Antigens; Arbitrary concentration; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; Enzyme immunoassay; Farmers lung; Fl; Fld; FLU; Fluid; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; species; spp; SUDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
{Index_val} |
|
|
|
0 |
| 99085-3 |
Napsin A Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Napsin A Ag [Presence] in Tissue by Immune stain |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
99085-3 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
Napsin A Ag Tiss Ql ImStn |
|
|
|
N |
|
Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Oncology; Ordinal; Pathology; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99086-1 |
p40 Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
p40 Ag [Presence] in Tissue by Immune stain |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
99086-1 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
p40 Ag Tiss Ql ImStn |
|
|
|
N |
|
Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Oncology; Ordinal; Pathology; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99087-9 |
Meningitis+Encephalitis pathogens panel |
- |
CSF |
Pt |
- |
Probe.amp.tar |
|
ACTIVE |
Meningitis+Encephalitis pathogens panel - Cerebral spinal fluid by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
99087-9 |
|
Probe.amp.tar |
|
|
Order |
|
|
|
0 |
Mening+Enc Pnl CSF NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; Enc; Enceph; Encephalomyelitis; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Mening+Enc Pnl; Meningitis Enceph Path CSF NAA; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.72 |
2.72 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 99088-7 |
Cryptococcus gattii+neoformans DNA |
PrThr |
CSF |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Cryptococcus gattii+neoformans DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
99088-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C gattii+neofor DNA CSF Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C gattii+neofor; C. gattii; Cerebral spinal fluid; Cerebrospinal Fl; Crypt; Crypto; Cryptococcal; Cryptococcosis; Cryptococcosus; Cryptococcus neoformans var gattii; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99089-5 |
Escherichia coli K1 DNA |
PrThr |
CSF |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Escherichia coli K1 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
99089-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
E coli K1 DNA CSF Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E coli K1; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 9909-3 |
P wave duration.lead V3 |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
P wave duration in lead V3 |
|
MIN |
DefinitionDescription |
|
|
ms |
|
|
|
|
|
|
EKG.MEAS |
|
9909-3 |
|
EKG |
|
|
Observation |
|
|
|
0 |
P wave dur L-V3 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; P prime; P wave dur L-V3; Painter's colic; PB; Plumbism; Point in time; P-wave interval; QNT; Quan; Quant; Quantitative; Random |
2.48 |
1.0i |
|
|
|
|
|
|
|
ms |
|
|
|
0 |
| 99090-3 |
Haemophilus influenzae DNA |
PrThr |
CSF |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Haemophilus influenzae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
99090-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Haem influ DNA CSF Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; H flu; H influenza; H influenzae; Haem influ; Haemoph; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99091-1 |
Listeria monocytogenes DNA |
PrThr |
CSF |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Listeria monocytogenes DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
99091-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
L monocytog DNA CSF Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; L monocytog; L monocytogenes; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Listeriosis; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99092-9 |
Neisseria meningitidis DNA |
PrThr |
CSF |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Neisseria meningitidis DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
99092-9 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
N men DNA CSF Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99093-7 |
Streptococcus agalactiae DNA |
PrThr |
CSF |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Streptococcus agalactiae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
99093-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Gp B Strep DNA CSF Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GBS; Gp B Strep; Group B; Group B Strep; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S agalactiae; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Steptococcus Group B; Strand Displacement Amplification; Strep; Strep B; Strep group B; Strept; Streptococci group B; TMA; Transcription mediated amplification |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99094-5 |
Streptococcus pneumoniae DNA |
PrThr |
CSF |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Streptococcus pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
99094-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
S pneum DNA CSF Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S pneumo; S pneumoniae; S pneumoniase DNA; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Spn; Strand Displacement Amplification; Strep; Strept; TMA; Transcription mediated amplification |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99095-2 |
Streptococcus pyogenes DNA |
PrThr |
CSF |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Streptococcus pyogenes DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
99095-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
S pyo DNA CSF Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GAS; Group A Strep; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S pyogenes; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Steptococcus Group A; Strand Displacement Amplification; Strep; Strept; Streptococci group A; Streptococcus group A; TMA; Transcription mediated amplification |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99096-0 |
Mycoplasma pneumoniae DNA |
PrThr |
CSF |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Mycoplasma pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
99096-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
M pneumo DNA CSF Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Enzootic pneumonia; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M pneumo; M pneumonia; M pneumoniae; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99097-8 |
Blastomyces dermatitidis Ab.IgG |
ACnc |
CSF |
Pt |
Qn |
IA |
|
ACTIVE |
Blastomyces dermatitidis IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
EIA Units |
|
|
|
|
|
|
MICRO |
|
99097-8 |
|
IA |
|
|
Both |
|
|
|
0 |
B dermat IgG CSF IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B dermat; B dermatitidis; Blasto; Blastomycosis; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
{EIA_index} |
|
|
|
0 |
| 99098-6 |
Blastomyces dermatitidis Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Blastomyces dermatitidis IgG Ab [Units/volume] in Serum by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
EIA units |
|
|
|
|
|
|
MICRO |
|
99098-6 |
|
IA |
|
|
Both |
|
|
|
0 |
B dermat IgG Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B dermat; B dermatitidis; Blasto; Blastomycosis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
{EIA_index} |
|
|
|
0 |
